Comparison of the inhibition potentials of icotinib and erlotinib against human UDP-glucuronosyltransferase 1A1

por Cheng, Xuewei, Lv, Xia, Qu, Hengyan, Li, Dandan, Hu, Mengmeng, Guo, Wenzhi, Ge, Guangbo, Dong, Ruihua
Publicado 2017

In-vivo relation between plasma concentration of sorafenib and its safety in Chinese patients with metastatic renal cell carcinoma: a single-center clinical study

por Mai, Haixing, Huang, Jun, Zhang, Yuanyuan, Qu, Nang, Qu, Hengyan, Mei, Guo-hui, Liu, Jiannan, Xu, Xiaojie, Chen, Lijun
Publicado 2017

Development and validation of a HPLC-MS/MS method with electrospray ionization for quantitation of potassium oxonate in human plasma: Application to a pharmacokinetic study

por HAO, GUANGTAO, BAI, SHAOBO, LIANG, HAIXIA, LIANG, YUGUANG, QU, HENGYAN, GAO, HONGZHI, LI, YUANYUAN, ZHENG, ZHUANJIE, WANG, XIAOFANG, LIU, ZEYUAN
Publicado 2013

Association analysis of SNPs present in plasma with adverse events and population pharmacokinetics in Chinese sunitinib treated patients with renal cell carcinoma

por Zhang, Yuanyuan, Mai, Haixing, Guo, Gang, Bi, Guofang, Hao, Guangtao, Li, Yuanyuan, Wang, Xiaofang, Cheng, Longmei, Wang, Jing, Dong, Ruihua, Liu, Zeyuan, Chen, Lijun, Qu, Hengyan
Publicado 2018